Great Point Partners-backed VitaLink Research Acquires Comprehensive Clinical Trials
August 12, 2019
VitaLink Research, a clinical research site business backed by Great Point Partners, has acquired West Palm Beach-based Comprehensive Clinical Trials (CCT). The acquisition expands VitaLink's women's health clinical trial capabilities and increases patient access across the Southeast; Dr. Ronald Ackerman will continue to lead the CCT business.
- Buyers
- VitaLink Research, Great Point Partners
- Targets
- Comprehensive Clinical Trials
- Sellers
- Dr. Ronald Ackerman (Founder of Comprehensive Clinical Trials)
- Platforms
- VitaLink Research
- Industry
- Healthcare Services
- Location
- Florida, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Velocity Clinical Research Acquires VitaLink Research and National Research Institute
September 22, 2021
Healthcare Services
Durham-based Velocity Clinical Research acquired two multi-site clinical research companies—VitaLink Research (six sites in South Carolina) and National Research Institute (five sites in the Los Angeles area)—adding 11 sites to its network. The deal expands Velocity's therapeutic reach and patient recruitment capabilities, creating one of the largest fully integrated site management organizations in the U.S.
-
Veristat Acquires The Clinical Trial Company Ltd (TCTC Group)
January 6, 2020
Healthcare Services
Veristat, a full-service CRO based in Southborough, Massachusetts, has acquired The Clinical Trial Company Ltd (TCTC Group), a Europe-headquartered contract research organization. The deal expands Veristat's European footprint and adds TCTC's expertise in gene and cell therapy, CNS and orphan disease clinical trials to Veristat's service offering.
-
Headlands Research Acquires Clinvest Research
May 4, 2023
Healthcare Services
Headlands Research, a multinational clinical trial site network, has acquired Clinvest Research, a Springfield, Missouri-based clinical research site that has conducted over 600 trials since 1996. The deal expands Headlands' chronic pain and endocrinology capabilities and increases participant access for trials in the United States.
-
Kohlberg Acquires Majority Stake in Worldwide Clinical Trials
August 7, 2023
Healthcare Services
An affiliate of Kohlberg & Company agreed to acquire a majority stake in Worldwide Clinical Trials, a global contract research organization (CRO) headquartered in Research Triangle Park, North Carolina. The transaction is a recapitalization in which prior investor TJC, L.P. retains a meaningful minority equity stake; terms were not disclosed. Kohlberg will partner with Worldwide's management (Matt Jennings to become chairman) to support continued growth of the company's clinical trial and bioanalytical capabilities.
-
Therapeutic Research Center (TRC) Acquires CriticalPoint and Clinical IQ
April 8, 2020
Healthcare Services
Therapeutic Research Center (TRC), a portfolio company of Levine Leichtman Capital Partners, has acquired CriticalPoint, LLC and Clinical IQ, LLC to expand its sterile compounding training, consulting and compliance capabilities. The deal augments TRC's education platform and strengthens its domain expertise in compounding, aseptic processing and USP compliance.
-
Altasciences Acquires WCCT Global
February 12, 2021
Healthcare Services
Altasciences acquired WCCT Global, an early‑stage clinical research organization (CRO) based in Southern California, expanding its West Coast clinical pharmacology capabilities and adding 180 clinical beds. The transaction, completed February 12, 2021, augments Altasciences’ Phase I/II services and expertise in specialized areas such as ethnobridging to support biopharmaceutical sponsors.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.